Teligent, Inc. (TLGTQ)

July 27, 2022 - TLGTQ was delisted (reason: shares cancelled)
0.0002
0.00 (0.00%)
Last trade price
0.00%
Market Cap 18,563
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 92.82M
EPS (ttm) -2.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,460
Open 0.0002
Previous Close 0.0002
Day's Range 0.0002 - 0.0002
52-Week Range 0.0001 - 0.5040
Beta 1.21
Analysts Sell
Price Target n/a
Earnings Date Jun 20, 2022

About TLGTQ

Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid products for branded and generic pharmaceutical cust... [Read more...]

Industry Drug Manufacturers-Specialty & Generic
Founded 1977
CEO Timothy Sawyer
Employees 142
Stock Exchange OTCMKTS
Ticker Symbol TLGTQ
Full Company Profile

Analyst Forecast

No stock price forecast available yet.

Price Target
n/a
Analyst Consensus: Sell
Stock Forecasts

News

Teligent to Pursue Asset Sale through Voluntary Chapter 11 Process

BUENA, N.J., Oct. 14, 2021 /PRNewswire/ -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company ("Teligent" or the "Company"), today announced that the Company has,...

11 months ago - PRNewsWire

Scott+Scott Attorneys at Law LLP Announces a Notice of Proposed Settlement of Class Action for the Teligent, Inc. Sec...

PHILADELPHIA--(BUSINESS WIRE)--If you purchased or acquired Teligent common stock from March 7, 2017 to November 6, 2017, your rights will be affected by a settlement.

1 year ago - Business Wire

Teligent, Inc. Announces Second Quarter 2021 Earnings Report and Provides Business Update

BUENA, N.J., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the second quarter of 2021 and...

1 year ago - GlobeNewsWire

Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders

Scheduled to Reconvene on July 21, 2021 Company Urgently Encourages Stockholders to Vote

1 year ago - GlobeNewsWire

Teligent: Q1 Earnings Insights

Shares of Teligent (NASDAQ:TLGT) rose 1.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 13.04% year over year to ($0.26), which may not compare ...

1 year ago - Benzinga

Teligent, Inc. Announces First Quarter 2021 Earnings Report and Provides Business Update

BUENA, N.J., May 25, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the first quarter of 2021 and p...

1 year ago - GlobeNewsWire

Teligent, Inc. to Hold Conference Call for First Quarter 2021 Financial Results on Tuesday May 25, 2020

BUENA, N.J., May 21, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey based generics pharmaceutical company, today announced they will hold a conferenc...

1 year ago - GlobeNewsWire

Teligent, Inc. Announces 2020 Year-End Earnings Report and Provides Business Update

BUENA, N.J., May 03, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the fourth quarter and year end...

1 year ago - GlobeNewsWire

Teligent Announces Hiring of Chief Financial Officer

BUENA, N.J., April 15, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, today announced the hiring and a...

1 year ago - GlobeNewsWire

Teligent, Inc. Announces Appointment of Carter Pate to Board of Directors

BUENA, N.J., Feb. 23, 2021 /PRNewswire/ -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey-based specialty generic pharmaceutical company, today announced it has appointed Car...

1 year ago - PRNewsWire

Teligent, Inc. Announces Appointment of William S. Marth to Board of Directors

BUENA, N.J., Feb. 16, 2021 /PRNewswire/ -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey-based specialty generic pharmaceutical company, today announced it has appointed ind...

1 year ago - PRNewsWire

Teligent Takes Strategic Steps to Recapitalize and Position Business for Success

BUENA, N.J., Jan. 28, 2021 /PRNewswire/ -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey-based specialty generic pharmaceutical company, today announced a series of strategi...

1 year ago - PRNewsWire

Teligent Regains Compliance with Nasdaq Filing Requirements and Nasdaq Minimum Market Value Rule

BUENA, N.J., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, previously received notice from T...

1 year ago - GlobeNewsWire

Teligent, Inc. Announces Third Quarter 2020 Results

BUENA, N.J., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter end...

1 year ago - GlobeNewsWire

Teligent: 7 Things for Investors to Know About TLGT Stock

Shares of TLGT stock are soaring on Monday ahead of a special shareholder vote to address Teligent's Nasdaq compliance. The post Teligent: 7 Things for Investors to Know About TLGT Stock appeared first ...

1 year ago - InvestorPlace

Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders

Scheduled to Reconvene on December 16 , 2020 Company Urgently Encourages Stockholders to Vote

1 year ago - GlobeNewsWire

TLGT LONG TERM SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Teligent, Inc. and...

LOS ANGELES--(BUSINESS WIRE)---- $TLGT #TLGT--TLGT LONG TERM SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Teligent, Inc.

2 years ago - Business Wire

Teligent Announces Completion of Series D Convertible Note Exchange

BUENA, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the closing of the i...

2 years ago - GlobeNewsWire

Teligent, Inc. Announces Second Quarter 2020 Results

BUENA, N.J., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ...

2 years ago - GlobeNewsWire

Teligent, Inc. to Hold Conference Call for Second Quarter 2020 Financial Results and Business Update on Wednesday Aug...

BUENA, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00AM ET on We...

2 years ago - GlobeNewsWire

Teligent Announces Completion of Series C Convertible Note Financing and Exchange

BUENA, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the closing of the is...

2 years ago - GlobeNewsWire

Teligent, Inc. Announces the Appointment of John Celentano as Chairman of the Board

BUENA, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, is pleased to announce that Joh...

2 years ago - GlobeNewsWire

Teligent, Inc. Announces Hiring of Chief Legal Officer and Corporate Secretary

BUENA, N.J., July 17, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, today announced the hiring of P...

2 years ago - GlobeNewsWire

Teligent Regains Compliance with NASDAQ Listing Requirements

BUENA, N.J., June 22, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced today that it receive...

2 years ago - GlobeNewsWire

Teligent Announces Conversion Rate Adjustment for its 7.0% Cash / 8.0% PIK Series B Senior Unsecured Convertible Note...

BUENA, N.J., June 03, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced today conversion rate...

2 years ago - GlobeNewsWire